about
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hem...
Read More
1.71
-0.05
(-2.84%)
58,656
XNAS Volume
XNAS 30 Jul, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Curis Inc is on 01 Aug 2025 for the purpose of Curis Inc Second Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Bearish
Curis Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..